Skip to main content

An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program (2003) / Chapter Skim
Currently Skimming:

Appendix B: Information-Gathering Meeting Agendas
Pages 105-112

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 105...
... ohn D Grabenstein, R.Ph., Ph.D., Clinical Operations, Anthrax Vaccine Immunization Program Agency 105
Read the entire page →
From page 106...
... Perkins, M.D., National Center for Infectious Diseases, CDC Adjourn Meeting II February 8, 2001 The Foundry Building 1055 Thomas Jefferson Street, NVV Washington, DC Agenda 9:00 a.m. Welcome, introductory remarks, and introductions by committee members and meeting attendees Philip Brachman, M.D., Chairman, Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program 9:15 Rev~ewofcharge Philip Brachman, M.D.
Read the entire page →
From page 107...
... Data mining in Vaccine Adverse Event Report System Betsy Cadwell, M.S.P.H., Mathematical Statistician, Data Management Division, National Immunization Program, CDC 1:15 Assessing the safety of anthrax vaccine: a meta-analysis Betsy Campbell, M.S.P.H. 2:00 Adjourn
Read the entire page →
From page 108...
... Welcome, introductory remarks, review of charge, and call to order Philip Brachman, M.D., Chairman 8:10 National Center for Infectious Diseases anthrax vaccine research program Bradley Perkins, M.D., Chief; Meningitis & Special Pathogens Branch' Division of Bacterial Mycotic Diseases, National Center for Infectious Diseases, CDC Update on human clinical Dial Nina Marano, D V.M., M.P.H., Medical Epidemiologist, Meningitis & Special Pathogens Branch, Division of Bacterial Mycotic Diseases, National CenterforInfectious Diseases, CDC S:40 Nonhuman primate studies DavidFAshforil, D
Read the entire page →
From page 109...
... Immune Response Laboratory, Meningitis & Special Pathogens Branch, Division of Bacterial Mycotic Diseases, National Centerforinfectious Diseases, CDC Break Sub-study: human leukocyte antigen (HLA) Robert Jacobson Progesterone Laurie Kamimoto, M.D., National Immunization Program, CDC SF-36 health survey Stacey Martin, M.S., National Immunization Program, CDC Lunch 12:30 p.m.
Read the entire page →
From page 110...
... use of AVA · The Vaccine Healthcare Center (VHC) Network partnership with DoD Rankly L`ouchart, R.N., M.P.H., Deputy Chief; Anthrax Vaccine Safety Activity, Epidemiology and Surveillance Division, National Immunization Program, CDC Addressing TOM Concerns and Input from External Expert Panels 9:45 10:45 Research priorities and the study of long-term health effects of AVA Michael McNeil, M.D., M.P.H., ChieJ; Anthrax Vaccine Safety Activity, Epidemiology and Surveillance Division, National Immunization Program, CDC Survey of military personnel about their knowledge, attitudes, and beliefs concerning AVA Deborah Gust, Ph.D., Behavioral Scientist, Vaccine Safety & Development Activity, Epid~emiology & Surveillance Division, National Immunization Program, CDC 1: ~ 5 Use of DMSS to test AVA adverse events hypotheses Ben Schwartz, M.D., Associate Directorfor Science, Epidemiology and Surveillance Division, National Immunization Program, CDC I l :45 Other AVA safety research activities and coliaborations~uestions and comments National Immunization Program staff
Read the entire page →
From page 111...
... V.M., M.P.H., Medical Epidemiologist, Meningitis & Special Pathogens 111 Branch, Division of Bacterial Mycotic Diseases, National Center for Infectious Diseases, CDC 2: ~ 5 Update on nonhuman primate study Jairam Lingappa, M.D., Ph.D., Medical Epidemiologist, Meningitis & Special Pathogens Branch, Division of Bacterial Mycotic Diseases, National Center for Infectious Diseases, CDC Dave Ashford, D V.M., M.P.H., D.Sc., Medical Epidemiologist, Meningitis & Special Pathogens Branch, Division of Bacterial Mycotic Diseases, National Centerfor Infec tious Diseases, CDC 3:00 Break 3: 15 Update on correlates of protection study Conrad Quinn, Ph.D., Medical Epidemiologist, Meningitis & Special Pathogens Branch, Division of Bacterial Mycotic Diseases, National Center for Infectious Diseases, CDC 4:00 Committee members' discussion: comments, questions, and answers ,1 5:00 Adjourn
Read the entire page →
From page 112...
... In one major component of this research, CDC's National Center for Infectious Diseases (NCID) and National Immunization Program (NIP)
Read the entire page →

Key Terms

  • national immunization
  • anthrax vaccine
  • surveillance division
  • vaccine safety
  • infectious diseases

  • pathogens branch
  • mycotic diseases
  • special pathogens
  • bacterial mycotic
  • medical epidemiologist

  • development activity
  • cdc anthrax
  • safety activity
  • vaccine program
  • cdc michael

  • safety development
  • activities associated
  • benjamin schwartz
  • foundry building
  • thomas jefferson

  • vaccine research
  • gina mootrey
  • research officer
  • cdc research
  • management division

  • diseases anthrax
  • conrad quinn
  • efficacy research
  • sponsor overview
  • deborah gust


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.